Cyclosporine in patients with severe steroid refractory ulcerative colitis in the era of infliximab. Review article

Scandinavian Journal of Gastroenterology

Volumn 48, Issue 2, 2013, Pages 131-135

  Rolny, Peter ^a   Vatn, Morten ^b  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

Cyclosporine; Infliximab; Steroids; Ulcerative colitis

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; INFLIXIMAB;

COLON RESECTION; FOLLOW UP; HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; ULCERATIVE COLITIS;

ADRENAL CORTEX HORMONES; ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL; COLECTOMY; COLITIS, ULCERATIVE; CYCLOSPORINE; DISEASE PROGRESSION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 84872708260     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.3109/00365521.2012.733954     Document Type: Review

References (77)

1. Travis SP, Farrant JM, Rickets C, Nolan DJ Mortensen NM, Kettlewell MG, et al. Predicting outcome in severe ulcerative colitis. Gut 1996;38:905-10 (Pubitemid 26231777)
2. Edwards FC, Truelove SC. The course and prognosis of ulcerative colitis. Gut 1963;4:299-315
3. Truelove SC, Witts LJ. Cortisone in ulcerative colitis. Final report on a therapeutic trial. Br Med J 1955;2:1041-8
4. Truelove SC, Jewell DP. Intensive intravenous regimen for severe attacks of ulcerative colitis. Lancet 1974;I:1067-70
5. Truelove SC, Willoughby CP, Lee EG, Kettlewell MGW. Further experience in the treatment of the severe attacks of ulcerative colitis. Lancet 1978;ii:1086-8 (Pubitemid 9052873)
6. Jarnerot G, Rolny P, Sandberg-Gerzén H. Intensive intravenous treatment of ulcerative colitis. Gastroenterology 1985; 89:10
7. Hart AL, Ng SC. Review article: The optimal management of acute ulcerative colitis. Aliment Pharmacol Ther 2010;32: 615-27
8. Turner D, Walsh CM, Steinhart AH, Griffiths AM. Response to corticosteroids in severe ulcerative colitis: A systematic review of the literature and a meta regression. Clin Gastroenterol Hepatol 2007;5:103-10 (Pubitemid 46096828)
9. Tysk C, Almer S, Andersson M, Befrits R, Hertevig E Kilander A, et al. Lindgren S Handläggning av akut svårt skov av ulcerös kolit. Nationella riktlinjer. Gastrokuriren 2008;3:35-6
10. Järnerot G, Hertevig E, Friis-Liby I, Blomquist L, Karlén P. Grännö Ch, et al. Infliximab as rescue therapy in severe to moderately severe ulcerative colitis: A randomized, placebocontrolled trial. Gastroenterology 2005;128:1805-11
11. Gustavsson A, Järnerot G, Hertevik E, Friis-Liby I Blomquist L, Karlén P, et al. Clinical trial: Colectomy after rescue therapy in ulcerative colitis - a 3-year follow up of the Swedish-Danish controlled infliximab study. Aliment Pharmacol Ther 2010;32:984-9
12. Wilhelm SM,Mc Kenney KA, Rivait KN, Kale-Pradhan PB. A review of infliximab use in ulcerative colitis. Clin Ther 2008;30:223-30 (Pubitemid 351474384)
13. Hart AL, Ng SC. Review article: The optimal medical management of acute severe ulcerative colitis. Aliment Pharmacol Ther 2010;32:615-27
14. Fabro M, Szabo H, Terrosu G, Avellini C, Tabuso M Fiorino G, et al. Acute severe colitis: Infliximab and/or cyclosporine? Curr Drug Targets 2011;12:1448-53
15. Brynskov J. Cyclosporine for inflammatory bowel disease: Mechanism and possible actions. Scand J Gastroenterol 1993;28:849-57 (Pubitemid 23294756)
16. Durai D, Hawthorne AB. Review article: How and when to use cyclosporine in ulcerative colitis. Aliment Pharmacol Ther 2005;22:907-16 (Pubitemid 41634871)
17. Arts J, D-Haens G, Zeegers M, Van Assche G, Hiele M D-Hoore A, et al. Long-term outcome of treatment with intravenous cyclosporine in patients with severe ulcerative colitis. Inflamm Bowel Dis 2004;10:73-8 (Pubitemid 38332164)
18. Filipi J, Allen PB, Hébuterne X, Peyrin-Biroulet L. Does anti TNF therapy reduce the requirement for surgery in ulcerative colitis? Curr Drug Targets 2011;12:1440-4
19. Rolny P, Sadik R. Longer term outcome of steroid refractory ulcerative colitis without subsequent oral cyclosporine therapy. Int J Colorectal Dis 2002;17:67-9 (Pubitemid 36067750)
20. Holme Ö, Thiis-Evensen E, Vatn MH. Treatment of fulminant ulcerative colitis with cyclosporine A. Scand J Gastroenterol 2009;44:1310-14
21. Campbell S, Travis S, Jewell D. Cyclosporine in acute ulcerative colitis: A long term experience. Eur J Gastroenterol Hepatol 2005;17:7
22. MoskovitzDN,VanAsscheG,MaenhoutB,Arts J,FerranteM Vermeire S, et al. Incidence of colectomy during long-term follow-up after cyclosporin-induced remission of severe ulcerative colitis. Clin Gastroenterol Hepatol 2006;4:760-5 (Pubitemid 43833506)
23. Sternthal MB, Murphy SJ, George J, Kornbluth A Lichtiger S, Present DH. Adverse events associated with the use of cyclosporine in patients with inflammatory bowel disease. Am J Gastroenterol 2008;103:937-43 (Pubitemid 351501092)
24. Doherty GA, Cheifetz AS. Management of acute severe ulcerative colitis. Expert Rev Gastroenterol Hepatol 2009;3:325-7
25. Burger D, Travis S. Conventional medical management of inflammatory bowel disease. Gastroenterology 2001;140: 1827-37
26. NgSC,KammMA.Therapeutic strategies for themanagement of ulcerative colitis. Inflamm Bowel Dis 2009;15:935-50
27. Van Assche G, Vermeire S, Rutgeerts P. Management of acute severe ulcerative colitis. Gut 2011;60:130-3
28. Kornbluth A, Sachar D; and the practice parameters committee of the American college of gastroenterology. Ulcerative colitis practice guidelines in adults: American college of gastroenterology, practice parameters committee. Am J Gastroenterol 2010;105:501-23
29. Travis SPL, Stange EF, Léman M, Oresland T Bemelman WA, Chowers Y, et al. European evidence based consensus on the management of the ulcerative colitis: Current management. JCC 2008;2:24-62 (Pubitemid 351179488)
30. Talley NJ, Abreu MT, Achkar J-P, Bernstein CN Dubinsky MC, Hanauer SB, et al. An evidence-based systematic review on medical therapies for inflammatory bowel disease. Am J Gastroenterol 2011;106:S2-S52
31. BittonA,BuieD,EnnsR,FeaganB, Jones JL,Marshall JL, et al. on behalf of the Canadian Association of Gastroenterology severe ulcerative colitis consensus group. Treatment of hospitalized adult patients with severe ulcerative colitis: Toronto consensus statements. Am J Gastroenterol 2012;107:179-94
32. Meier J, Sturm A. Current treatment of ulcerative colitis. WJG 2011;17:3204-12
33. Mowat C, Cole A, Windsor A, Ahmad T, Arnott I Driscoll R, et al. Guidelines for the management of inflammatory bowel disease in adults. Gut 2011;60:571-607
34. SanbornWJ.Acritical reviewof cyclosporine therapy in inflammatory bowel disease. Inflamm bowel Dis 1995;1:48-63
35. Van Assche G, D-Haens G, Noman M, Vermeire S, Hiele F Asnong K, et al. Randomized, double blind comparison of 4 mg/kg versus 2 mg/kg intravenous cyclosporine in severe ulcerative colitis. Gastroenterology 2003;125:1025-31 (Pubitemid 37193449)
36. Rayner CK, Mc Cormack G, Emmanuel AV, Kamm MA. Long-term results of low dose intravenous cyclosporine for acute severe ulcerative colitis. Aliment Pharmacol Ther 2003;18:303-8 (Pubitemid 37046709)
37. Actis GC, Ottobrelli A, Pera A, Barletti C, Ponti V, Pinna- Pintor M, et al. Continuouly infused cyclosporine at low dose is sufficient to avoid emergency colectomy in acute attacks of ulcerative colitis without need for high dose steroids. J Clin Gastroenterol 1993;17:10-11
38. Murphy SJ, Kornbluth A, Present DH. Cyclosporine in acute colitis. Am J Gatroenterol 2008;103:2654-5
39. Bojic D, Radojicic Z, Nedeljkovic-Protic M, Jewell DP Travis SPL. Long-term outcome after admission for acute severe ulcerative colitis I Oxford: The 1992-1993 cohort. Inflamm Bowel Dis 2009;15:823-8
40. Fernandez-Banares F, Bertran X, Esteve-Comas M Cabré E, Menacho M, Humbert P, et al. Azathioprine is useful in maintaining long-term remission induced by intravenous cyclosporine in steroid refractory severe ulcerative colitis. Am J Gastroenterol 1996;12:2498-9 (Pubitemid 26406297)
41. Domenéc E, Garcia-Plamella E, Bernal I, Rosinach M Cabré E, Fluvià L, et al. Azathioprine without oral cyclosporine in the long-term maintenance of remission induced by intravenous cyclosporine in severe steroid refractory ulcerative colitis. Aliment Pharmacol Ther 2002;16:2061-5 (Pubitemid 36009169)
42. Actis GC, Fadda M, David E, Sapiro A. Colectomy rate in steroid-refractory colitis initially responsive to cyclosporin: A long term retrospective cohort study BMC. Gastroenterology 2007;7:13
43. ChefetzAS, Stern J,Garud S,GoldsteinE,MalterL,MossAC et al. Cyclosporine is safe and effective in patients with severe ulcerative colitis. J Clin Gastroenterol 2011;45:107-1112
44. Mc Dermott RP, Green JA, Ashley CC. What is the optimal therapy for severe ulcerative colitis? Inflamm Bowel Dis 2008;14-S228-31
45. Sharkey L, Bredin F, Nightingale A, Parkes M. The use of cyclosporine A in acute steroid refractory ulcerative colitis: Long term outcomes. J Crohns Colitis 2011;5:91-4
46. Weber A, Fein F, Koch S, Dupont-Gossart AC, Mantion G Heyd B, et al. Treatment of ulcerative colitis refractory to steroid therapy by oral micro emulsion cyclosporine (Neoral). Inflamm Bowel Dis 2006;12:1131-5 (Pubitemid 44847470)
47. Kumar P, Rowbotan D. Cyclosporine A as rescue therapy for steroid refractory acute severe colitis: Oral administration is as effective as intravenous. J Crohns Colitis 2012;6:S141
48. Walch A, Meshkat M, Vogelsang H, Novacek G, Dejacoc C Angelberger S, et al. Long term outcome in patients with ulcerative colitis treated with intravenous cyclosporine A is determined by previous exposure to azathioprine. J Crohns Colitis 2010;4:398-404
49. SjöbergM,Walch A, Meshkat M, Gustavsson A, Järnerot G Volgesang H, et al. Infliximab or cyclosporine as rescue therapy in hospitalized patients with steroid refractory ulcerative colitis: A retrospective observational study. Inflamm Bowel Dis 2011;18:212-18
50. Dean KE, Hikaka J, Huakau JT, Walmsley RS. Infliximab or cyclosporine for acute severe ulcerative colitis: A retrospective analysis. J Gastroenterol Hepatol 2012;27:487-92
51. Branche J, Allez M, Bouhnik Y, Filippi J, et al. Cyclosporine versus infliximab in acute severe colitis. J Crohns Colitis 2011;5:S8
52. Bossa F, Caruso N, Accadia A, Merta AM, Ippolito GA Niro GA, et al. Oral cyclosporine versus infliximab in patients with severe ulcerative colitis refractory to iv steroids. Preliminary data of a controlled, randomized study. J Crohns Colitis 2009;3:S61
53. Jakobovits SL, Jewell DP, Travis SPL. Infliximab for the treatment of ulcerative colitis: Outcomes in Oxford from 2000 to 2006. Aliment Pharmacol Ther 2007;25:1055-60 (Pubitemid 46587696)
54. Lees CW, Heys D, Ho GT, Noble CL, Shand AG Mowat C, et al. on behalf of Scottish society of gastroenterology infliximab group. A retrospective analysis of the efficacy and safety of infliximab as rescue therapy in acute severe ulcerative colitis. Aliment Pharmacol Ther 2007;26:411-19
55. Hyde GM, Jewell DP, Kettlewell MGW, Mortensen C. Cyclosporin for severe ulcerative colitis does not increase the rate of postoperative complications. Dis Colon Rectum 2001;44:1436-40 (Pubitemid 32952547)
56. Norgård BM, Nielsen J, Qvist N, Gradel KO de Muckadel OBS, Kjeldsen J. Preoperative use of anti-TNF agents and the risk of postoperative complications in patients with ulcerative colitis-a nationwide cohort studies. Aliment Pharmacol Ther 2012;35:1301-9
57. Mor IJ, Vogel JD, da Luz Moreira A, Shen B, hammel J Remzi FH. Infliximab in ulcerative colitis is associated with an increased risk of postoperative complications after restorative proctocolectomy. Dis Colon Rectum 2008;51: 1202-7
58. Yang Z, Wu Q, Wu K, Fan D. Meta-analysis: Pre-operative infliximab treatment and short term post-operative complications in patients with ulcerative colitis. Aliment Pharmacol Ther 2010;31:486-92
59. Nguyen GC, Prather CM. Is keeping the colon the ultimate marker of success in ulcerative colitis? Gastroenterology 2009;137:1204-6
60. Teisner AS, Ainsworth MA, Brynskov J. Long term effects and colectomy rates in ulcerative colitis patients treated with infliximab: A Danish single centre experience. Scand J Gastroenterol 2010;45:1457-6
61. Williet N, Pillot C, Oussalah A, Billioud V, Chevaux J-B Bressler L, et al. Incidence of and impact of medications on colectomy in newly diagnosed ulcerative colitis in the era of biologics. Inflamm Bowel Dis 2011;Epub ahead of print
62. Ehteshami-Afshar S, Nikfar S, Rezaie A, Abdollahi M. A systematic review and meta-analysis of the effects of infliximab on the rate of colectomy and post-operative complications in patients with inflammatory bowel disease. Arch Med Sci 2011;7:1000-12
63. Aratari A, Papi C, Clemente V, Moretti A, Luchetti R Koch M, et al. Colectomy rates in acute severe ulcerative colitis in the infliximab era. Dig Liver Dis 2008;40:821-6
64. Chetfetz AS, Rosenberg L. Infliximab decreases colectomy rates in moderate to severe ulcerative colitis: Big news or big deal? Inflamm Bowel Dis 2011;17:1626-8
65. D-Haens G, Lemmens L, Geboes K, Vandeputte L Van Acker F, Mortelmans L, et al. Intravenous cyclosporine versus intravenous corticosteroids as single therapy for severe attacksofulcerativecolitis.Gastroenterology2001;120:1323-9
66. Ochsenkühn T, Sackman M, Göke B. Infliximab for acute not steroid-refractory ulcerative colitis: A randomized pilot study. Eur J Gastroenterol Hepatol 2004;16:1167-71 (Pubitemid 39488789)
67. Habal FM, Huang VW. Review article: A decision - making algorithm for the management of pregnancy in the inflammatory bowel disease patient. Aliment Pharmacol Ther 2012; 35:501-15
68. Branche J, Corot A, Bourreile A, Coffin B, de Vos M de Saussure P, et al. Cyclosporine treatment of steroid refractory ulcerative colitis during pregnancy. Inflamm Bowel Dis 2009;15:1044-8
69. Arnott ID, Leiper K, Down C. Otcome of acute severe ulcerative colitis: Data from the UK National IBD Audit. Gastroenterology 2010;138S-S106
70. Stenner JMC, White P, Gould SR, Lim AG. Audit on the management of severe ulcerative colitis in a DGH. Gut 2001; 48:A87
71. De Silva S, Ma C, Proulx M-C, Crespin M, Kaplan BS Hubbard J, et al. Postoperative complications and mortality following colectomy for ulcerative colitis. Clin gastroenterol Hepatol 2011;9:972-80
72. Becker JM, Stucchi AF. Treatment of choice for acute severe steroid refractory ulcerative colitis is colectomy. Inflamm Bowel Dis 2009;15:150-1
73. Öresland T. Review article: Colon saving medical therapy vs. colectomy - the case for colectomy. Aliment Pharmacol Ther 2006;24:74-9 (Pubitemid 44326425)
74. Roberts SE, Williams JG, Yeates D, Goldacre M. Mortality in patients with and without colectomy admitted to hospital for ulcerative colitis and Crohn-s disease: Record linkage studies. BMJ 2007;335:1033
75. ArseneauKO,Sultan S, ProvenzaleDT,OnkenJ, Bickston SJ Foley E, et al. Do patient preferences influence decisions on treatment for patients with steroid-refractory ulcerative colitis? Clin Gastroenterol Hepatol 2006;4:1135-42 (Pubitemid 44311640)
76. Kamm MA. Early surgical intervention in ulcerative colitis. Gut 2004;53:308-9 (Pubitemid 38125524)
77. ÖreslandT,MoumB.Kirurgi, inflammatorisk tarm sykdomog biologiskbehandling. TidskrNorLegeforen2009;129:2389-90